Dr. Daisuke Nishizawa, Ph.D., is a Research Fellow and Head of the Laboratory of Psychotropic Drug Development at the National Center of Neurology and Psychiatry (NCNP), Japan. He received his academic training in biological anthropology and neuroscience and has devoted his career to investigating the genetic basis of individual differences in drug responses and disease susceptibility. His research focuses on human genetics, pharmacogenomics, and precision medicine, particularly in pain, addiction, and neuropsychiatric disorders. He has conducted genome-wide association studies (GWAS), candidate gene analyses, methylation studies, and transcriptomic analyses to identify genetic factors associated with opioid sensitivity, postoperative nausea and vomiting, substance use disorders, and chronic pain. Dr. Nishizawa is particularly recognized for his studies on genetic polymorphisms in OPRM1, KCNJ6, and other genes associated with pain sensitivity and opioid responses, as well as recent findings on opioid-induced nausea and the sedative effects of midazolam. He has authored more than 90 peer-reviewed publications and contributed to several patents related to pharmacogenomic evaluation methods. He is a member of several professional societies in pharmacology, neuroscience, pain research, and human genetics, and continues to promote personalized medicine for pain management, addiction, and psychiatric disorders.
Tokyo Metropolitan Institute of Medical Science
Tokyo, Japan
National Center of Neurology and Psychiatry (NCNP)
Tokyo, Japan
Department of Neuropsychopharmacology
The Japan Society of Human Genetics, Travel Award
The Japan Society of Human Genetics (JSHG), Tokyo, Tokyo, Japan
Travel Award
The Asian College of Neuropsychopharmacology, Fellowship Award
Asian College of Neuropsychopharmacology, Tokyo, Tokyo, Japan
Fellowship Award
JSNP Excellent Presentation Award for CINP 2012
The Japanese Society of Neuropsychopharmacology, Tokyo, Tokyo, Japan
JSNP Excellent Presentation Award
JSNP Excellent Presentation Award for CINP 2014
The Japanese Society of Neuropsychopharmacology, Tokyo, Japan
JSNP Excellent Presentation Awar
The Japanese Medical Society of Alcohol and Drug Studies excellent presentation award for 2014
The Japanese Medical Society of Alcohol and Drug Studies (JMSAS), Tokyo, Tokyo, Japan
The Japanese Medical Society of Alcohol and Drug Studies (JMSAS) excellent presentation award
The Japanese Pharmacological Society (JPS) 19th excellent paper award
The Japanese Pharmacological Society (JPS), Tokyo, Tokyo, Japan
The Japanese Pharmacological Society (JPS) excellent paper award
JSNP Excellent Presentation Award for AsCNP 2015
The Japanese Society of Neuropsychopharmacology, Tokyo, Japan
JSNP Excellent Presentation Award for AsCNP
Tokyo Metropolitan Institute of Medical Science staff commendation for fiscal year 2015
Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
Tokyo Metropolitan Institute of Medical Science staff commendation
JSNP Excellent Presentation Award for CINP 2016
The Japanese Society of Neuropsychopharmacology, Tokyo, Japan
JSNP Excellent Presentation Award for CINP
INRC Travel Awards for 2016
International Narcotics Research Conference, Media, Pennsylvania, USA
INRC Travel Awards
Senior Scientist or Principal Investigator
National Center of Neurology and Psychiatry, Tokyo, Japan
01 Aug 2024 - 31 Jul 2026
Senior Scientist or Principal Investigator
Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
01 Apr 2013 - 31 Jul 2024
Post Doctoral Researcher
Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
01 Apr 2011 - 31 Mar 2013
Graduate Student or Post Graduate
Tokyo Institute of Psychiatry, Tokyo, Japan
01 Apr 2004 - 31 Mar 2011